wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33765196-7E54361A-62B8-438A-A4C9-B1F8D38FB223
Q33765196-7E54361A-62B8-438A-A4C9-B1F8D38FB223
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33765196-7E54361A-62B8-438A-A4C9-B1F8D38FB223
When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank.
P2860
Q33765196-7E54361A-62B8-438A-A4C9-B1F8D38FB223
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33765196-7E54361A-62B8-438A-A4C9-B1F8D38FB223
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d893718ba8a75816ad2dda0bc20693cf59860fd
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.